Showing 33–48 of 147 results
-
ESBRIET (pirfenidone) capsules and film-coated tablets, for oral use Initial U.S. Approval: 2014
Read more -
EVENITY (romosozumab-aqqg) injection. FDA-Approved
Read more -
EXKIVITY (mobocertinib) capsules
Read more -
EXPAREL (bupivacaine liposome injectable suspension). Initial U.S. Approval: 1972. Get Access In India
Read more -
EYLEA (aflibercept) Injection. For Intravitreal Injection. Initial U.S. Approval:2011
Read more -
fam-trastuzumab deruxtecan-nxki for injection, for intravenous use Initial U.S. Approval: 2019
Read more -
FETROJA (cefiderocol) for injection, for intravenous use. FDA Approved
Read more -
FOTIVDA (tivozanib) capsules
Read more -
GAZYVA (obinutuzumab) injection, for intravenous infusion. Initial U.S. Approval: 2013
Read more -
ICLUSIG (ponatinib) tablets for oral use. Initial U.S. Approval: 2012
Read more -
IDHIFA (enasidenib) tablets, for oral use. Initial U.S. Approval: 2017
Read more -
IMJUDO (tremelimumab-actl) injection
Read more -
IMLYGIC (talimogene laherparepvec). Suspension for intralesional injection Initial U.S. Approval: 2015
Read more -
INGREZZA (valbenazine) capsules, for oral use. Initial U.S. Approval: 2017
Read more -
INREBIC (fedratinib) capsules, for oral use. Initial U.S. Approval: 2019
Read more -
INTELENCE 25 mg tablets
Read more